Johnson & Johnson’s spinoff, Kenvue, debuted on the stock market at $25.53 a share, a possible sign that public markets are thawing.
Health, Wellness & Biotech
The Series A will help the company create a pipeline of radiopharmaceuticals starting with a treatment for prostate cancer.
Global venture funding in April reached $21 billion, the second-lowest amount recorded in a single month since July 2022.
Large deals were plentiful this week, as U.S.-based startups raised five nine-figure rounds — with two of those going to biotech startups. In fact...
Each year, in the U.S. alone, hundreds of funded startups get acquired by private, venture-backed companies. This year is shaping up as no exception.
After a bumpy first quarter for venture capital, the second quarter is in full swing. Here's a handful of rounds that may have been overlooked.
Bed Bath & Beyond may be shuttering, but the vision it sold lives on. An analysis of Crunchbase data unearthed a decent cohort of recently funded...
Not as many big funding rounds this week, but still some rather large ones — with two crossing the $200 million mark.
Florida in 2023 is no longer a growing startup funding ecosystem. It is a shrinking one — with funding statewide receding even faster than it is...
Abdera Therapeutics, a newly formed cancer therapeutics upstart, has emerged out of stealth armed with $142 million in a combined Series A and Series...
The funding comes just a month after the FDA cleared Noah Medical’s lung bronchoscopy device for commercial use in the U.S.
67.1K Followers